Retinoic acid and 6-formylindolo(3,2–b)carbazole (FICZ) combination therapy reveals putative targets for enhancing response in non-APL AML

In non-APL AML, identification of a signaling signature would predict potentially actionable targets to enhance differentiation effects of all-trans-retinoic acid (RA) and make combination differentiation therapy realizable. Components of such a signaling machine/signalsome found to drive RA-induced...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Leuk Lymphoma
Main Authors: Bunaciu, Rodica P., MacDonald, Robert J., Jensen, Holly A., Gao, Feng, Wang, Xin, Johnson, Lynn, Varner, Jeffrey D., Yen, Andrew
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6586535/
https://ncbi.nlm.nih.gov/pubmed/30570341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2018.1543880
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados